A former executive with InVentiv Health, Terrell "Terry" Herring has served as president of commercial operations for Mission Pharmacal Company since 2010. In addition to his role with Mission, Terrell "Terry" Herring serves on the advisory board for BioAgilytix, a bioanalytical testing laboratory with locations in North Carolina and Germany. A major area of focus for BioAgilytix is gene therapy and its growing prevalence as a treatment option for diseases such as cancer, Parkinson's, Alzheimer's, and diabetes. Over 200 gene therapy products for cancer were in commercial development as of 2016, while the total number of in-development gene therapy products doubled from 2012 to 2015. The therapy works by using sections of DNA to initiate genetic material into the cells of a patient. The resulting DNA carries a functioning gene which corrects the effects of a particular disease-causing mutation. The adeno-associated virus (AAV) is most commonly used as a carrier to deliver genes to the cells. BioAgilytix's scientists have a wealth of experience analyzing AAV gene therapy options, while the company invests in a variety of platforms used by its customers to facilitate innovation in the field.
0 Comments
Since 2011, Terrell Herring has served as the president of Alamo Pharma Services, Inc., in Doylestown, Pennsylvania. Terrell (“Terry”) Herring dedicates a significant amount of his time to the community and formerly functioned as a trustee of Big Brothers Big Sisters of America (BBBSA). This organization provides critical mentorship and programs to at-risk youth across the nation.
BBBSA recently announced 13 grants worth a total of $560,000 to support “Bigs in Blue” programs across the nation. This new program encourages law enforcement officers to become mentors to children in their local communities. Already, the program has had an overwhelmingly positive impact in bridging the gap between youth and law enforcement in terms of trust and respect. The new grants will help expand existing Bigs in Blue programs and create new ones. In addition, seven participating cities will receive $250,000 in grants annually for the next three years from WellCare, the corporate sponsor of the new initiative. Law enforcement officers who volunteer for the program go through a vetting process and receive training before they are matched with a little. After the matching, Bigs in Blue go through the same monitoring processes of all volunteers with the organization. |
AuthorTerrell Herring began working at Mission Pharmacal Company in 2010, bringing more than 25 years of experience in the pharmaceutical industry to his role as President of Commercial Operations. Archives
February 2018
Categories
All
|